Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 21,493 | 13,336 | 9,654 | 4,923 | 3,152 |
| Depreciation Amortization | 5,742 | 4,518 | 3,783 | 3,504 | 1,025 |
| Other Working Capital | -20,428 | -3,080 | -5,989 | -8,549 | -415 |
| Other Operating Activity | 0 | -1 | 0 | 0 | 0 |
| Operating Cash Flow | $6,807 | $14,773 | $7,447 | $-122 | $3,762 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,860 | -4,442 | -2,131 | -2,298 | -9,354 |
| Net Acquisitions | -3,500 | 0 | -108 | -9,877 | -1,484 |
| Other Investing Activity | -22,906 | -6,913 | -6,545 | -8,685 | -5,257 |
| Investing Cash Flow | $-42,266 | $-11,355 | $-8,783 | $-20,860 | $-16,094 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 159,731 | 2,447 | 2,360 | 29,383 | 14,217 |
| Financing Cash Flow | $159,731 | $2,447 | $2,360 | $29,383 | $14,217 |
| Exchange Rate Effect | -198 | 371 | -59 | -504 | -168 |
| Beginning Cash Position | 25,179 | 18,942 | 17,977 | 9,330 | 7,612 |
| End Cash Position | 149,252 | 25,179 | 18,942 | 17,227 | 9,330 |
| Net Cash Flow | $124,074 | $6,237 | $965 | $7,897 | $1,718 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,807 | 14,773 | 7,447 | -122 | 3,762 |
| Free Cash Flow | 6,807 | 14,773 | 7,447 | -122 | 3,762 |